ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
608 hedge funds and large institutions have $20.4B invested in Alexion Pharmaceuticals Inc in 2018 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 200 increasing their positions, 234 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
608
Holders Change
+25
Holders Change %
+4.29%
% of All Funds
13.57%
Holding in Top 10
8
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-55.56%
% of All Funds
0.18%
New
101
Increased
200
Reduced
234
Closed
71
Calls
$184M
Puts
$201M
Net Calls
-$17.3M
Net Calls Change
-$18.2M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$516M |
| 2 |
JPMorgan Chase & Co
New York
|
+$77.1M |
| 3 |
Millennium Management
New York
|
+$64M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$58.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$44.3M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$311M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
-$107M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$107M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$88.3M |
| 5 |
O
OrbiMed
New York
|
-$81.2M |
